Publications by authors named "Angelo Ruggiero"

Claim this Profile
E
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years.
Luca Mastorino, Paolo Dapavo, Martina Burlando, Paolo Gisondi, Carlo Alberto Maronese, Angelo Ruggiero

Psoriasis (Auckl)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.
Sara Cacciapuoti, Teresa Battista, Luca Potestio, Massimiliano Scalvenzi, Matteo Megna, Angelo Ruggiero

Clin Exp Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective study.
Luca Potestio, Angelo Ruggiero, Fabrizio Martora, Matteo Megna

Arch Dermatol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study.
Antonio Portarapillo, Valeria Esposito, Matteo Megna, Luca Potestio, Rosita Comune, Angelo Ruggiero

Clin Exp Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced.
Matteo Megna, Angelo Ruggiero, Ginevra Torta, Fabrizio Martora, Mariateresa Bianco

Clin Exp Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis.
Teresa Battista, Vincenzo Picone, Matteo Noto, Luca Potestio, Angelo Ruggiero

Expert Opin Drug Saf· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis.
Francesco Caso, Mauro Fatica, Mario Ferraioli, Matteo Megna, Luca Potestio, Angelo Ruggiero

Expert Opin Biol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up.
Rosita Comune, Angelo Ruggiero, Antonio Portarapillo, Alessia Villani, Matteo Megna

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation.
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, Federica Feo, Angelo Ruggiero

Expert Opin Drug Saf· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Psoriasis Patients with Serious Infectious Diseases.
Matteo Megna, Giuseppe Lauletta, Nello Tommasino, Antonia Salsano, Teresa Battista, Angelo Ruggiero

Adv Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.
Matteo Megna, Angelo Ruggiero, Fabrizio Martora, Ylenia Vallone, Gianluca Guerrasio

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study.
Matteo Megna, Angelo Ruggiero, Nello Tommasino, Claudio Brescia, Fabrizio Martora

Clin Cosmet Investig Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor-alpha presence in post mortem cardiac tissue of psoriatic patients.
Paolo Romanelli, Emma Lanuti, Mark Shuman, Robert Norman, Sarah Alenezi, Angelo Ruggiero

Arch Dermatol Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report.
Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio, Teresa Battista, Angelo Ruggiero

Clin Cosmet Investig Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab-associated inflammatory arthritis: a literature review.
Maddalena Napolitano, Angelo Ruggiero, Cataldo Patruno

Clin Exp Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Past, the Present and the Future of Teledermatology: A Narrative Review.
Nello Tommasino, Matteo Megna, Sara Cacciapuoti, Alessia Villani, Fabrizio Martora, Angelo Ruggiero

Clin Cosmet Investig Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter].
Luca Potestio, Fabrizio Martora, Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero

Clin Cosmet Investig Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
Luca Potestio, Fabrizio Martora, Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero

Clin Cosmet Investig Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab.
Matteo Megna, Angelo Ruggiero, Antonia Salsano, Giuseppe Lauletta, Antonio Portarapillo

Clin Cosmet Investig Dermatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Fabrizio Martora, Luigi Guerriero, Angelo Ruggiero

Expert Opin Drug Saf· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics.
Angelo Ruggiero, Antonio Portarapillo, Matteo Megna, Cataldo Patruno, Maddalena Napolitano

Pediatric Health Med Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK Inhibitors in Psoriatic Disease.
Matteo Megna, Luca Potestio, Angelo Ruggiero, Sara Cacciapuoti, Francesco Maione

Clin Cosmet Investig Dermatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data.
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, Luigi Fornaro, Luca Potestio, Angelo Ruggiero

Clin Cosmet Investig Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas.
Sara Cacciapuoti, Luca Potestio, Gianluca Guerrasio, Gabriella Fabbrocini, Massimiliano Scalvenzi, Angelo Ruggiero

Clin Cosmet Investig Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.
Luca Potestio, Teresa Battista, Sara Cacciapuoti, Angelo Ruggiero, Fabrizio Martora

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis